These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 39122208)
1. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials. Szondy I; Meznerics FA; Lőrincz K; Kemény LV; Walter A; Mohammed AA; Hegyi P; Kiss N; Bánvölgyi A Int J Infect Dis; 2024 Oct; 147():107186. PubMed ID: 39122208 [TBL] [Abstract][Full Text] [Related]
2. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Molina JM; Bercot B; Assoumou L; Rubenstein E; Algarte-Genin M; Pialoux G; Katlama C; Surgers L; Bébéar C; Dupin N; Ouattara M; Slama L; Pavie J; Duvivier C; Loze B; Goldwirt L; Gibowski S; Ollivier M; Ghosn J; Costagliola D; Lancet Infect Dis; 2024 Oct; 24(10):1093-1104. PubMed ID: 38797183 [TBL] [Abstract][Full Text] [Related]
3. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. Bachmann LH; Barbee LA; Chan P; Reno H; Workowski KA; Hoover K; Mermin J; Mena L MMWR Recomm Rep; 2024 Jun; 73(2):1-8. PubMed ID: 38833414 [TBL] [Abstract][Full Text] [Related]
5. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Cornelisse VJ; Riley B; Medland NA Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437 [TBL] [Abstract][Full Text] [Related]
6. Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants. Fredericksen RJ; Perkins R; Brown CE; Cannon C; Lopez C; Cohee A; Dombrowski JC; Cohen S; Malinski C; Powell M; Luetkemeyer AF; Celum C; Christopoulos K AIDS Patient Care STDS; 2024 Apr; 38(4):155-167. PubMed ID: 38656217 [TBL] [Abstract][Full Text] [Related]
7. The impact of HIV preexposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: a systematic review and meta-analysis. Georgiadis N; Papamichail D; Lytras T; Halkitis PN; Tzanakaki G; Kornarou E; Vassilakou NT; Sergentanis TN AIDS; 2024 Jun; 38(7):1033-1045. PubMed ID: 38669203 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Doxycycline as Pre-exposure and/or Post-exposure Prophylaxis to Prevent Sexually Transmitted Diseases: A Systematic Review and Meta-analysis. Boschiero MN; Sansone NMS; Ribeiro LM; Marson FAL Sex Transm Dis; 2024 Sep; ():. PubMed ID: 39316078 [TBL] [Abstract][Full Text] [Related]
9. Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP). Werner RN; Schmidt AJ; Potthoff A; Spornraft-Ragaller P; Brockmeyer NH; J Dtsch Dermatol Ges; 2024 Mar; 22(3):466-478. PubMed ID: 38123738 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of postexposure prophylaxis with doxycycline (Doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis. Sokoll PR; Migliavaca CB; Döring S; Traub U; Stark K; Sardeli AV Sex Transm Infect; 2024 Aug; ():. PubMed ID: 39097410 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention. Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546 [TBL] [Abstract][Full Text] [Related]
12. Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. Werner RN; Gaskins M; Nast A; Dressler C PLoS One; 2018; 13(12):e0208107. PubMed ID: 30507962 [TBL] [Abstract][Full Text] [Related]
13. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women. Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM; N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022 [TBL] [Abstract][Full Text] [Related]
14. [Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections]. Filén F; Eriksen J; Missailidis C Lakartidningen; 2024 Aug; 121():. PubMed ID: 39101261 [TBL] [Abstract][Full Text] [Related]
15. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial. Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444 [TBL] [Abstract][Full Text] [Related]
16. Early adopters of doxycycline as post-exposure prophylaxis to prevent bacterial sexually transmitted infections in a real-world clinical setting. Chan PA; Malyuta Y; Parent H; Tao J; Erbe M; Salhaney P; Maynard M; DeWitt W; Reisopoulos A; Nunn A Sex Transm Infect; 2024 Aug; 100(6):339-342. PubMed ID: 38821877 [TBL] [Abstract][Full Text] [Related]
17. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L; Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440 [TBL] [Abstract][Full Text] [Related]
18. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study. Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V; Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787 [TBL] [Abstract][Full Text] [Related]
19. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men. van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228 [No Abstract] [Full Text] [Related]
20. Self-Reported PrEP Use and Risk of Bacterial STIs Among Ontarian Men Who Are Gay or Bisexual or Have Sex With Men. Tran NK; Welles SL; Roy JA; Brennan DJ; Chernak E; Goldstein ND Ann Fam Med; 2024 Sep; 22(5):437-443. PubMed ID: 39191461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]